Victoza (liraglutide)
Patient Assistance Program Guide — Novo Nordisk Patient Assistance Program (PAP)
Do You Qualify?
Income
Up to $60,240 for a single person
Insurance
Must be uninsured or a Medicare Part D beneficiary with no other prescription coverage. Patients with commercial insurance are generally ineligible for PAP but may use savings cards.
Residency
U.S. citizen or legal resident with a valid U.S. address.
Income Limits (400% FPL)
Income thresholds calculated at 400% of 2025 FPL. Medicare Part D patients must meet additional spending criteria.
Based on 2025 HHS Federal Poverty Level guidelines.
# Victoza (Liraglutide) Patient Assistance Program Guide
### Novo Nordisk PAP — Presented by RX Advantages
---
Who Qualifies for the Novo Nordisk Patient Assistance Program (PAP)?
If you need Victoza (liraglutide) but cannot afford it, the Novo Nordisk Patient Assistance Program (PAP) may be able to provide it to you at no cost. To qualify, you generally need to earn below $60,240 per year as a single-person household. Your income limit rises with each additional person in your home. On the insurance side, you must be either uninsured or enrolled in Medicare Part D with no other prescription drug coverage — patients who have active commercial insurance are typically not eligible for this program, though a separate savings card option may be available to you. If you meet both the income and insurance requirements, this program can cover your Victoza supply and ship it directly to your home.
---
About Victoza (Liraglutide)
Victoza is an injectable prescription medication approved by the FDA to help manage Type 2 Diabetes Mellitus in adults and children aged 10 and older. It also carries FDA approval to help reduce the risk of major adverse cardiovascular events — such as heart attack and stroke — in adults with Type 2 diabetes who also have established heart disease. Victoza belongs to a drug class called GLP-1 receptor agonists, which work by mimicking a hormone involved in blood sugar regulation. Without insurance or assistance, Victoza can cost well over $1,000 per month, placing it out of reach for many people who depend on it. The Novo Nordisk PAP exists specifically to help bridge that gap.
---
Income Eligibility: Full Breakdown
The Novo Nordisk PAP uses income thresholds set at 400% of the 2025 Federal Poverty Level (FPL). The table below shows the maximum annual income allowed based on your household size:
| Household Size | Max Annual Income |
|---|---|
| 1 person | $60,240 |
| 2 persons | $81,760 |
| 3 persons | $103,280 |
| 4 persons | $124,800 |
For households larger than four people, the limit continues to increase — contact Novo Nordisk directly at (866) 310-7549 to confirm the threshold for your specific situation.
Your income is typically verified using your most recent federal tax return (Form 1040), a W-2, three months of recent pay stubs, or a Social Security Award Letter if applicable. If your income has recently changed and your prior-year tax return no longer reflects your current situation, pay stubs may be a better option to document your actual earnings.
If your income is above these limits, you may not qualify for the PAP — but you are not out of options. The "Alternatives" section below outlines other programs that may still help you access Victoza or a comparable medication at a lower cost.
---
Insurance Requirements Explained
Understanding whether your insurance situation makes you eligible is one of the most important steps before applying.
---
Step-by-Step: How to Apply
Follow these steps to apply for the Novo Nordisk PAP for Victoza:
1. Check your eligibility first. Review the income table and insurance requirements above to make sure you likely qualify before investing time in the application.
2. Gather your documents. You will need:
- A completed Novo Nordisk PAP application form
- Proof of income (tax return/Form 1040, W-2, recent pay stubs, or Social Security Award Letter)
- A valid Victoza prescription signed by your healthcare provider
3. Get your provider involved. Your doctor or their office staff will need to sign the application. Many providers are familiar with this process — call their office and ask for the prior authorization or patient assistance coordinator.
4. Submit your application. You have multiple ways to apply:
- Online: Visit https://www.novocare.com/diabetes/help-with-costs/pap.html to start a digital application.
- By phone: Call (866) 310-7549 to apply with assistance or ask questions.
- By fax: Send your completed paperwork to (866) 443-1068.
5. Wait for confirmation. Processing typically takes 7 to 10 business days after Novo Nordisk receives your complete application.
6. Watch for your shipment. Once approved, Victoza is shipped directly to your home address. Make sure someone is available to receive temperature-sensitive medications.
---
What to Expect: Timeline and Delivery
After submitting a complete application, most patients receive a decision within 7 to 10 business days. You or your healthcare provider's office will typically be notified of approval. Victoza is shipped directly to your home, so you do not need to go to a pharmacy or your doctor's office for pickup. Be prepared to store the medication properly upon arrival, as it requires refrigeration. Your enrollment in the program is valid for one year, after which you will need to reapply and submit updated income documentation. Novo Nordisk may send a reauthorization reminder, but it is a good idea to track your renewal date yourself to avoid any gaps in your supply.
---
Alternatives If You Don't Qualify
If the Novo Nordisk PAP is not the right fit for you, consider these options:
1. Biosimilar alternatives: A liraglutide injection biosimilar is available and may be significantly less expensive than brand-name Victoza. Ask your doctor whether a biosimilar is appropriate for your treatment plan.
2. Victoza Savings Card (commercially insured patients): If you have private insurance, Novo Nordisk offers a savings card that may lower your copay. Apply at https://www.victoza.com/savings-and-support/savings-card.html.
3. State Pharmaceutical Assistance Programs (SPAPs): Many states run their own drug assistance programs, particularly for older adults or those with disabilities. Eligibility and benefits vary by state — search "[your state] pharmaceutical assistance program" to find local options.
4. NeedyMeds.org: This free, independent database lists hundreds of assistance programs by drug name or condition. Visit https://www.needymeds.org to search for additional help that may complement or replace the Novo Nordisk PAP.
---
*This guide is for informational purposes only and does not constitute medical or legal advice. Eligibility determinations are made solely by Novo Nordisk. Program terms may change — verify current requirements at [https://www.novocare.com/diabetes/products/victoza/let-us-help/pap.html](https://www.novocare.com/diabetes/products/victoza/let-us-help/pap.html) before applying.*
---
Documents You'll Need
If You Don't Qualify for the Assistance Program
Biosimilar / Generic Alternatives
FDA-approved alternatives to Victoza: Liraglutide injection. Ask your prescriber if one of these is clinically appropriate for your condition.
Manufacturer Savings Card (for insured patients)
Novo Nordisk offers a savings card that may reduce your out-of-pocket cost if you have commercial insurance. Ask your prescriber or pharmacist for current savings card details.
Common Questions
Once Novo Nordisk receives your complete application — including your proof of income and signed prescription — processing typically takes 7 to 10 business days. After approval, your medication is shipped directly to your home. Incomplete applications may take longer, so make sure all documents are included before submitting.
Yes, Medicare Part D beneficiaries may apply, but only if they have no other prescription drug coverage in addition to Part D. There are also additional spending criteria that apply specifically to Medicare patients. Call Novo Nordisk at (866) 310-7549 to find out whether your specific situation qualifies before you apply.
If your income exceeds the program threshold, you would generally not qualify for the PAP. However, you may still have options, including the Victoza savings card for commercially insured patients, biosimilar liraglutide, state pharmaceutical assistance programs, or other resources listed on NeedyMeds.org. It is worth exploring these alternatives before giving up on finding affordable coverage.
Yes. The Novo Nordisk PAP requires annual reauthorization. Before your enrollment period ends, you will need to submit a new application along with updated proof of income. It is a good idea to keep track of your enrollment date so you can start the renewal process early and avoid any gaps in receiving your medication.
If you are approved through the Novo Nordisk PAP, Victoza is shipped directly to your home address. You do not need to pick it up at a pharmacy or your provider's office. Because liraglutide requires refrigeration, make sure someone is available to receive the package and store it properly right away.
Ready to Apply for Victoza Assistance?
RX Advantages handles the entire Novo Nordisk Patient Assistance Program (PAP) application on your behalf — paperwork, physician coordination, and refill tracking. It takes about 15 minutes to get started.
No SSN required on the web form · From $49.95/month